牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

海特生物（300683）

5.4

综合诊断：5.4分打败了60%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
有加速上涨趋势。
长期趋势：
已有41家主力机构披露2025-12-31报告期持股数据，持仓量总计4963.47万股，占流通A股40.66%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

7.5分

5.7分

5.2分

1.9分

4.2分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：7.5技术面打败了84%的股票技术面评分前10的股票

近期的平均成本为35.10元。多头行情中，并且有加速上涨趋势。

技术面得分最高的股票

平均成本

近期的平均成本为35.10元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"35.10","date":1777450743,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。

[{"date":"2026.04.30","stock":"0.26","trade":"-0.13","ind":"-0.09"},{"date":"2026.04.29","stock":"-0.14","trade":"0.19","ind":"1.96"},{"date":"2026.04.28","stock":"-1.56","trade":"0.43","ind":"-1.10"},{"date":"2026.04.27","stock":"9.20","trade":"-0.06","ind":"0.37"},{"date":"2026.04.24","stock":"1.86","trade":"0.07","ind":"-0.69"},{"date":"2026.04.23","stock":"-2.63","trade":"-1.89","ind":"-0.88"},{"date":"2026.04.22","stock":"-2.79","trade":"1.12","ind":"1.30"},{"date":"2026.04.21","stock":"0.47","trade":"-1.11","ind":"0.10"},{"date":"2026.04.20","stock":"-0.88","trade":"0.69","ind":"0.55"},{"date":"2026.04.17","stock":"-2.92","trade":"-1.80","ind":"0.60"},{"date":"2026.04.16","stock":"-0.93","trade":"-0.04","ind":"2.05"},{"date":"2026.04.15","stock":"-1.44","trade":"0.14","ind":"-0.97"},{"date":"2026.04.14","stock":"0.67","trade":"1.73","ind":"1.61"},{"date":"2026.04.13","stock":"-0.97","trade":"-1.22","ind":"0.69"},{"date":"2026.04.10","stock":"-3.34","trade":"0.70","ind":"2.24"},{"date":"2026.04.09","stock":"-3.01","trade":"-1.86","ind":"-0.33"},{"date":"2026.04.08","stock":"-7.46","trade":"2.51","ind":"4.79"},{"date":"2026.04.07","stock":"-4.99","trade":"0.66","ind":"0.36"},{"date":"2026.04.03","stock":"-7.42","trade":"-3.06","ind":"-0.99"},{"date":"2026.04.02","stock":"-2.79","trade":"-0.64","ind":"-1.60"},{"date":"2026.04.01","stock":"12.50","trade":"5.25","ind":"1.70"}]

海特生物,深证成指,医疗服务指数

压力支撑

该股压力位为34.89元，支撑位为34.33元。

[{"text":"\u538b\u529b\u4f4d","value":"34.89","date":1777478400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"34.33","date":1777478400,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.7资金面打败了86%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：05月01日 20:31

机构今日流向(万元)	-2751.99	机构5日流向(万元)	-5953.30
机构10日流向(万元)	-13580.70	机构20日流向(万元)	-18216.53

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加534.15万股，其中基金净减仓2家，主力净增仓22家，请投资者中长期谨慎为宜。

截止2025-12-31，共41家主力机构（基金35家，一般法人3家，QFII3家），持仓量总计4963.47万股，占流通A股40.66%
其中，基金持仓与2025-06-30相比：
增仓：1家，增持 0.18万股
减仓：3家，减持 2.01万股
新出现在主力名单中：34家，持有650.03万股
从主力名单中消失：12家，原持有114.05万股

消息面诊股

诊断结果：5.2消息面打败了27%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-04-24
一般消息	分红转增	不分配不转增	2026-04-24
一般消息	重大事项	公司股东股份解押	2026-03-23
一般消息	募资投向	公司购买资产	2026-03-19
一般消息	高管变动	因个人原因	2026-02-05
重大利空	业绩预告	预计增亏	2026-01-23
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	高管变动	取消监事会	2025-11-07
一般消息	分红转增	不分配不转增	2025-08-26
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	1条	1条	0条

行业面诊股

诊断结果：1.9行业面打败了18%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.04.30","price":"-0.09","value":"-0.13"},{"date":"2026.04.29","price":"1.96","value":"0.19"},{"date":"2026.04.28","price":"-1.10","value":"0.43"},{"date":"2026.04.27","price":"0.37","value":"-0.06"},{"date":"2026.04.24","price":"-0.69","value":"0.07"},{"date":"2026.04.23","price":"-0.88","value":"-1.89"},{"date":"2026.04.22","price":"1.30","value":"1.12"},{"date":"2026.04.21","price":"0.10","value":"-1.11"},{"date":"2026.04.20","price":"0.55","value":"0.69"},{"date":"2026.04.17","price":"0.60","value":"-1.80"},{"date":"2026.04.16","price":"2.05","value":"-0.04"},{"date":"2026.04.15","price":"-0.97","value":"0.14"},{"date":"2026.04.14","price":"1.61","value":"1.73"},{"date":"2026.04.13","price":"0.69","value":"-1.22"},{"date":"2026.04.10","price":"2.24","value":"0.70"},{"date":"2026.04.09","price":"-0.33","value":"-1.86"},{"date":"2026.04.08","price":"4.79","value":"2.51"},{"date":"2026.04.07","price":"0.36","value":"0.66"},{"date":"2026.04.03","price":"-0.99","value":"-3.06"},{"date":"2026.04.02","price":"-1.60","value":"-0.64"},{"date":"2026.04.01","price":"1.70","value":"5.25"}]

深证成指,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	药康生物	30.96%	5.37%	6.0分
2	普瑞眼科	29.90%	18.74%	6.6分
3	爱尔眼科	11.25%	3.55%	5.3分
4	华康洁净	9.45%	-5.42%	4.4分
5	百诚医药	8.46%	2.40%	5.5分
6	奥浦迈	8.16%	1.01%	4.8分
7	华厦眼科	5.82%	2.94%	6.1分
8	药明康德	5.53%	9.34%	6.0分
9	昭衍新药	5.17%	4.21%	5.3分
10	毕得医药	4.17%	10.47%	5.5分
11	药石科技	4.07%	3.61%	5.0分
12	博济医药	3.47%	6.34%	5.8分
13	凯莱英	3.04%	12.10%	5.5分
14	成都先导	2.73%	6.71%	6.3分
15	皓元医药	1.86%	1.03%	5.1分
16	金域医学	1.71%	-4.91%	4.7分
17	皓宸医疗	1.08%	12.00%	5.8分
18	迪安诊断	0.73%	-0.15%	5.9分
19	兰卫医学	0.29%	8.97%	6.0分
20	大东方	0.00%	7.30%	5.4分
21	通策医疗	-0.71%	-1.10%	5.5分
22	何氏眼科	-1.44%	4.25%	5.7分
23	诺禾致源	-1.52%	0.28%	4.9分
24	光正眼科	-1.78%	8.89%	6.3分
25	百奥赛图	-2.70%	-3.10%	6.2分
26	华大基因	-2.87%	2.17%	4.8分
27	泰格医药	-3.24%	-1.62%	5.9分
28	康龙化成	-3.52%	-1.05%	4.6分
29	美迪西	-3.95%	-6.79%	4.6分
30	ST中珠	-3.97%	-5.67%	4.5分
31	南模生物	-4.76%	-1.64%	4.6分
32	益诺思	-4.79%	-1.46%	4.9分
33	万邦医药	-4.90%	3.71%	4.4分
34	三博脑科	-5.39%	-4.51%	4.6分
35	美年健康	-5.40%	3.23%	5.1分
36	泓博医药	-5.46%	-3.23%	5.3分
37	博腾股份	-5.69%	-0.75%	4.2分
38	和元生物	-6.09%	1.95%	4.2分
39	澳洋健康	-6.16%	2.14%	5.6分
40	贝瑞基因	-6.81%	2.99%	5.1分
41	新里程	-8.70%	-1.70%	4.8分
42	*ST生物	-8.93%	-2.65%	4.9分
43	创新医疗	-9.81%	-5.94%	4.7分
44	-	-10.25%	-13.78%	分
45	诺思格	-10.99%	-4.98%	5.6分
46	普蕊斯	-11.13%	-6.78%	5.0分
47	国际医学	-11.20%	0.44%	4.5分
48	百花医药	-12.10%	-2.54%	4.2分
49	大湖股份	-12.36%	-2.40%	5.3分
50	盈康生命	-15.41%	-1.66%	5.1分
51	阳光诺和	-16.14%	-5.67%	4.2分
52	睿智医药	-19.57%	-6.29%	4.5分
53	金凯生科	-20.80%	-16.73%	4.5分
54	九洲药业	-22.27%	-16.63%	4.2分
55	海特生物	-27.55%	9.62%	5.4分
56	诚达药业	-30.82%	3.18%	4.6分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.2基本面打败了2%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/102 ， 24/102。

[{"date":"2026-03-31","value":"-1.07","vol":"0.96"},{"date":"2025-12-31","value":"-10.16","vol":"2.21"},{"date":"2025-09-30","value":"-6.84","vol":"3.24"},{"date":"2025-06-30","value":"-1.65","vol":"2.24"},{"date":"2025-03-31","value":"-0.58","vol":"0.88"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-1.07	-10.16	-6.84	-1.65	-0.58
行业(%)	0.96	2.21	3.24	2.24	0.88

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"38.47","vol":"34.16"},{"date":"2025-12-31","value":"42.64","vol":"34.36"},{"date":"2025-09-30","value":"41.81","vol":"36.06"},{"date":"2025-06-30","value":"40.74","vol":"36.21"},{"date":"2025-03-31","value":"44.38","vol":"35.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	38.47	42.64	41.81	40.74	44.38
行业(%)	34.16	34.36	36.06	36.21	35.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 33/102 ， 47/102。

[{"date":"2026-03-31","value":"1.52","vol":"16.75"},{"date":"2025-12-31","value":"-16.57","vol":"8.22"},{"date":"2025-09-30","value":"-6.45","vol":"3.06"},{"date":"2025-06-30","value":"-3.36","vol":"2.87"},{"date":"2025-03-31","value":"18.79","vol":"-0.73"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	1.52	-16.57	-6.45	-3.36	18.79
行业(%)	16.75	8.22	3.06	2.87	-0.73

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-65.44","vol":"79.49"},{"date":"2025-12-31","value":"-233.48","vol":"23.26"},{"date":"2025-09-30","value":"-297.78","vol":"20.05"},{"date":"2025-06-30","value":"-72.10","vol":"-63.31"},{"date":"2025-03-31","value":"15.81","vol":"-22.07"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-65.44	-233.48	-297.78	-72.10	15.81
行业(%)	79.49	23.26	20.05	-63.31	-22.07

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 48/102 ， 28/102。

[{"date":"2026-03-31","value":"0.06","vol":"0.10"},{"date":"2025-12-31","value":"0.20","vol":"0.44"},{"date":"2025-09-30","value":"0.15","vol":"0.32"},{"date":"2025-06-30","value":"0.10","vol":"0.21"},{"date":"2025-03-31","value":"0.05","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.06	0.20	0.15	0.10	0.05
行业(次)	0.10	0.44	0.32	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.21","vol":"3.44"},{"date":"2025-12-31","value":"3.24","vol":"15.84"},{"date":"2025-09-30","value":"2.53","vol":"10.95"},{"date":"2025-06-30","value":"1.57","vol":"7.15"},{"date":"2025-03-31","value":"0.80","vol":"3.62"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	1.21	3.24	2.53	1.57	0.80
行业(次)	3.44	15.84	10.95	7.15	3.62

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-1.58","vol":"0.86"},{"date":"2025-12-31","value":"-0.42","vol":"20.95"},{"date":"2025-09-30","value":"-12.24","vol":"16.52"},{"date":"2025-06-30","value":"-6.99","vol":"16.38"},{"date":"2025-03-31","value":"-31.78","vol":"-0.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-1.58	-0.42	-12.24	-6.99	-31.78
行业	0.86	20.95	16.52	16.38	-0.79

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.51","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.63","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.51	-	0.63	-
行业	0.00	0.89	0.01	0.91	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/102 ， 38/102。

[{"date":"2026-03-31","value":"4.17","vol":"3.37"},{"date":"2025-12-31","value":"3.98","vol":"3.64"},{"date":"2025-09-30","value":"4.60","vol":"3.67"},{"date":"2025-06-30","value":"4.89","vol":"3.57"},{"date":"2025-03-31","value":"4.76","vol":"3.68"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	4.17	3.98	4.60	4.89	4.76
行业	3.37	3.64	3.67	3.57	3.68

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.58","vol":"2.78"},{"date":"2025-12-31","value":"3.63","vol":"3.00"},{"date":"2025-09-30","value":"4.11","vol":"2.94"},{"date":"2025-06-30","value":"4.35","vol":"2.87"},{"date":"2025-03-31","value":"4.21","vol":"2.97"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	2.58	3.63	4.11	4.35	4.21
行业	2.78	3.00	2.94	2.87	2.97

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/102 ， 46/102。

[{"date":"2026-03-31","value":"15.68","vol":"32.97"},{"date":"2025-12-31","value":"15.80","vol":"32.98"},{"date":"2025-09-30","value":"14.91","vol":"32.60"},{"date":"2025-06-30","value":"14.71","vol":"33.58"},{"date":"2025-03-31","value":"15.03","vol":"32.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	15.68	15.80	14.91	14.71	15.03
行业(%)	32.97	32.98	32.60	33.58	32.05

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.19","vol":"0.97"},{"date":"2025-12-31","value":"0.19","vol":"0.97"},{"date":"2025-09-30","value":"0.18","vol":"0.92"},{"date":"2025-06-30","value":"0.17","vol":"0.96"},{"date":"2025-03-31","value":"0.18","vol":"0.96"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.19	0.19	0.18	0.17	0.18
行业(%)	0.97	0.97	0.92	0.96	0.96

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"-0.14","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.21","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.69","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-2.31","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[海特生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]